Epigenetic regulation of the electrophysiological phenotype of human embryonic stem cell-derived ventricular cardiomyocytes: insights for driven maturation and hypertrophic growth.

Epigenetic regulation is implicated in embryonic development and the control of gene expression in a cell-specific manner. However, little is known about the role of histone methylation changes on human cardiac differentiation and maturation. Using human embryonic stem cells (hESCs) and their derived ventricular (V) cardiomyocytes (CMs) as a model, we examined trimethylation of histone H3 lysine 4 (H3K4me3) and lysine 27 (H3K27me3) on promoters of genes associated with cardiac electrophysiology, contraction, and Ca(2+) handling. To avoid ambiguities due to heterogeneous chamber-specific types, hESC-derived ventricular cardiomyocytes (VCMs) were selected by dual zeocin-GFP expression under the transcriptional control of the MLC2v promoter and confirmed electrophysiologically by its signature action potential phenotype. High levels of H3K4me3 are present on pluripotency genes in hESCs with an absence of H3K27me3. Human ESC-VCMS, relative to hESCs, were characterized by a profound loss of H3K27me3 and an enrichment of H3K4me3 marks on cardiac-specific genes, including MYH6, MYH7, MYL2, cTNT, and ANF. Gene transcripts encoding key voltage-gated ion channels and Ca(2+)-handling proteins in hESC-VCMs were significantly increased, which could be attributed to a distinct pattern of differential H3K4me3 and H3K27me3 profiles. Treatment of hESC-VCMs with the histone deacetylase inhibitor valproic acid increased H3K4me3 on gene promoters, induced hypertrophic growth (as gauged by cell volume and capacitance), and augmented cardiac gene expression, but it did not affect electrophysiological properties of these cells. Hence, cardiac differentiation of hESCs involves a dynamic shift in histone methylation, which differentially affects VCM gene expression and function. We conclude that the epigenetic state of hESC-VCMs is dynamic and primed to promote growth and developmental maturation, but that proper environmental stimuli with chromatin remodeling will be required to synergistically trigger global CM maturation to a more adult-like phenotype.

Cordyceps militaris extract stimulates Cl(-) secretion across human bronchial epithelia by both Ca(2+)(-) and cAMP-dependent pathways.

ETHNOPHARMACOLOGICAL RELEVANCE: The caterpillar fungus Cordyceps militaris (CM; Clavicipitaceae) is a well-known traditional Chinese medicine that can be artificially cultivated on a large scale. We have previously demonstrated that its stimulatory action on ion transport in human airway epithelia is similar to Cordyceps sinensis (Clavicipitaceae), which has been traditionally used to treat respiratory diseases. AIM OF THE STUDY: To investigate the signal transduction mechanism(s) underlying CM-induced ion transport activity in cultured human bronchial epithelia. MATERIALS AND METHODS: 16HBE14o-, a human bronchial epithelial cell line, was used to study the regulation of ion transport by the water extract of CM. CM extract was added to the apical or basolateral aspect of the epithelia. In subsequent experiments, different Cl(-) channel and K(+) channel blockers, adenylate cyclase and protein kinase A (PKA) inhibitors, and an intracellular Ca(2+) chelator were used to examine the involvement of apical Cl(-) and basolateral K(+) channels in mediating CM-induced Cl(-) secretion and the underlying signal transduction mechanism(s). PKA activity was also measured in 16HBE14o- cells. RESULTS: CM stimulated Cl(-) secretion across 16HBE14o- monolayers in a dose-dependent manner. Cl(-) secretion could be inhibited by apical application of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl(-)channel blocker and the calcium-activated Cl(-) channel (CaCC) blocker. Cl(-) secretion was sensitive to basolateral application of different K(+) channel blockers. Similar inhibitory patterns were obtained in nystatin-permeabilized epithelia. The CM-induced Cl(-) secretion could be inhibited by adenylate cyclase and PKA inhibitors as well as an intracellular Ca(2+) chelator. Data from the PKA assay suggested that CM extract caused a significant increase in PKA activity compared with untreated control epithelia. CONCLUSIONS: These results suggest that CM extract stimulated Cl(-) secretion across human bronchial epithelia, possibly via apical CFTR and CaCC, and the basolateral K(+) channels are involved in driving apical Cl(-) exit. The underlying signal transduction mechanisms involve both cAMP- and Ca(2+)-dependent pathways.